PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Cardiac rhythm management devices - Market size and forecast 2018-2023 • Cardiac monitoring devices - Market size and forecast 2018-2023 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS • Increasing number of acquisition and strategic collaborations • Increasing R&D focus • Increasing utilization of cardiac implants PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott Laboratories • Abiomed Inc. • Asahi Kasei Corp. • Biotronik Inc. • Boston Scientific Corp. • General Electric Co. • Hill-Rom Holdings Inc. • Koninklijke Philips NV • Medtronic Plc • SCHILLER AG PART 13: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 14: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global medical devices market Exhibit 03: Segments of global medical devices market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: Cardiac rhythm management devices - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Cardiac rhythm management devices - Year-over-year growth 2019-2023 (%) Exhibit 22: Cardiac monitoring devices - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Cardiac monitoring devices - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 29: North America - Year-over-year growth 2019-2023 (%) Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Europe - Year-over-year growth 2019-2023 (%) Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Asia - Year-over-year growth 2019-2023 (%) Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 35: ROW - Year-over-year growth 2019-2023 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Abbott Laboratories - Vendor overview Exhibit 46: Abbott Laboratories - Business segments Exhibit 47: Abbott Laboratories - Organizational developments Exhibit 48: Abbott Laboratories - Geographic focus Exhibit 49: Abbott Laboratories - Segment focus Exhibit 50: Abbott Laboratories - Key offerings Exhibit 51: Abiomed Inc. - Vendor overview Exhibit 52: Abiomed Inc. - Business segments Exhibit 53: Abiomed Inc. - Organizational developments Exhibit 54: Abiomed Inc. - Geographic focus Exhibit 55: Abiomed Inc. - Key offerings Exhibit 56: Asahi Kasei Corp. - Vendor overview Exhibit 57: Asahi Kasei Corp. - Business segments Exhibit 58: Asahi Kasei Corp. - Organizational developments Exhibit 59: Asahi Kasei Corp. - Geographic focus Exhibit 60: Asahi Kasei Corp. - Segment focus Exhibit 61: Asahi Kasei Corp. - Key offerings Exhibit 62: Biotronik Inc. - Vendor overview Exhibit 63: Biotronik Inc. - Business segments Exhibit 64: Biotronik Inc. - Organizational developments Exhibit 65: Biotronik Inc. - Key offerings Exhibit 66: Boston Scientific Corp. - Vendor overview Exhibit 67: Boston Scientific Corp. - Business segments Exhibit 68: Boston Scientific Corp. - Organizational developments Exhibit 69: Boston Scientific Corp. - Geographic focus Exhibit 70: Boston Scientific Corp. - Segment focus Exhibit 71: Boston Scientific Corp. - Key offerings Exhibit 72: General Electric Co. - Vendor overview Exhibit 73: General Electric Co. - Business segments Exhibit 74: General Electric Co. - Organizational developments Exhibit 75: General Electric Co. - Geographic focus Exhibit 76: General Electric Co. - Segment focus Exhibit 77: General Electric Co. - Key offerings Exhibit 78: Hill-Rom Holdings Inc. - Vendor overview Exhibit 79: Hill-Rom Holdings Inc. - Business segments Exhibit 80: Hill-Rom Holdings Inc. - Organizational developments Exhibit 81: Hill-Rom Holdings Inc. - Geographic focus Exhibit 82: Hill-Rom Holdings Inc. - Segment focus Exhibit 83: Hill-Rom Holdings Inc. - Key offerings Exhibit 84: Koninklijke Philips NV - Vendor overview Exhibit 85: Koninklijke Philips NV - Business segments Exhibit 86: Koninklijke Philips NV - Organizational developments Exhibit 87: Koninklijke Philips NV - Geographic focus Exhibit 88: Koninklijke Philips NV - Segment focus Exhibit 89: Koninklijke Philips NV - Key offerings Exhibit 90: Medtronic Plc - Vendor overview Exhibit 91: Medtronic Plc - Business segments Exhibit 92: Medtronic Plc - Organizational developments Exhibit 93: Medtronic Plc - Geographic focus Exhibit 94: Medtronic Plc - Segment focus Exhibit 95: Medtronic Plc - Key offerings Exhibit 96: SCHILLER AG - Vendor overview Exhibit 97: SCHILLER AG - Product segments Exhibit 98: SCHILLER AG - Organizational developments Exhibit 99: SCHILLER AG - Key offerings Exhibit 100: Validation techniques employed for market sizing Exhibit 101: Definition of market positioning of vendors

Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Biotronik Inc., Boston Scientific Corp., General Electric Co., Hill-Rom Holdings Inc., Koninklijke Philips NV, Medtronic Plc, and SCHILLER AG.